Suppliers and packagers for generic pharmaceutical drug: quetiapine fumarate

quetiapine fumarate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Accord Hlthcare	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET, EXTENDED RELEASE;ORAL	206252	ANDA	Accord Healthcare Inc.	16729-132-12	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-132-12)	2017-11-30
Accord Hlthcare	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET, EXTENDED RELEASE;ORAL	090681	ANDA	Accord Healthcare Inc.	16729-095-12	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-095-12)	2019-01-01
Accord Hlthcare	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET, EXTENDED RELEASE;ORAL	090681	ANDA	Accord Healthcare Inc.	16729-096-12	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-096-12)	2019-01-01

Quetiapine Fumarate Supplier Landscape

Last updated: February 19, 2026

Quetiapine fumarate, a second-generation atypical antipsychotic used in treating schizophrenia, bipolar disorder, and major depressive disorder, has a robust global supply chain. Key suppliers of the active pharmaceutical ingredient (API) are concentrated in India and China, with a few established players in Europe. Patent expirations have led to a competitive generics market, driving demand for cost-effective, high-quality API sources.

Key API Manufacturers and Their Capabilities

Multiple manufacturers produce quetiapine fumarate API, catering to diverse market needs concerning volume, quality certifications, and pricing.

• India-Dominant Production: India is the primary manufacturing hub for quetiapine fumarate API. Companies like Aurobindo Pharma, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries are significant suppliers. These entities leverage large-scale manufacturing facilities and established supply chain networks to offer competitive pricing. Their output is often characterized by adherence to GMP standards and supply to major generic drug manufacturers globally.

  • Aurobindo Pharma: Operates multiple WHO-GMP and USFDA-approved manufacturing sites. Specializes in high-volume API production. [1]
  • Dr. Reddy's Laboratories: Possesses a broad portfolio of APIs, including antipsychotics. Holds USFDA, EMA, and other international regulatory approvals. [2]
  • Sun Pharmaceutical Industries: A major global pharmaceutical company with substantial API manufacturing capabilities. Facilities comply with international regulatory standards. [3]

• Chinese Suppliers: China also plays a crucial role in the quetiapine fumarate API market. Manufacturers like Zhejiang Huahai Pharmaceutical and Shandong Xinhua Pharmaceutical are notable. These suppliers often compete on price and volume.

  • Zhejiang Huahai Pharmaceutical: A significant producer of APIs, including cardiovascular and central nervous system drugs. Holds USFDA and EDQM certifications. [4]
  • Shandong Xinhua Pharmaceutical: One of China's largest pharmaceutical manufacturers, with a long history of API production. Holds various international certifications. [5]

• European Presence: While less dominant in volume, European manufacturers contribute to the supply chain, often focusing on niche markets or specialized quality requirements. Companies like Vamson Labs in France have been involved in quetiapine fumarate API production.

  • Vamson Labs (France): Has been identified as a manufacturer of quetiapine fumarate API. Specific production scale and certifications vary.

Geographic Concentration of Manufacturing

The overwhelming majority of quetiapine fumarate API production is geographically concentrated.

• India: Accounts for an estimated 60-70% of global quetiapine fumarate API production.
• China: Accounts for approximately 20-30% of global quetiapine fumarate API production.
• Europe: Represents a smaller, yet significant, share, often catering to specific regulatory markets.

Regulatory Compliance and Certifications

Suppliers for the pharmaceutical industry must meet stringent regulatory requirements. For quetiapine fumarate API, key certifications include:

• US Food and Drug Administration (USFDA): Essential for supplying the United States market.
• European Directorate for the Quality of Medicines & HealthCare (EDQM): Issues Certificates of Suitability to the monographs of the European Pharmacopoeia (CEP).
• World Health Organization Good Manufacturing Practices (WHO-GMP): A widely recognized standard.
• Other National Regulatory Authorities: Such as PMDA (Japan), TGA (Australia), Health Canada.

Manufacturers frequently obtain multiple certifications to access diverse global markets. The availability of Drug Master Files (DMFs) or Active Substance Master Files (ASMFs) is also critical for formulators.

Supply Chain Dynamics and Market Trends

The quetiapine fumarate market is influenced by generic competition, patent expiries, and evolving regulatory landscapes.

Impact of Patent Expirations

The primary patent for quetiapine fumarate has long expired, opening the market to generic manufacturers. This has led to:

• Increased Competition: A larger number of generic drug producers entering the market.
• Price Pressure: Downward pressure on API pricing due to heightened competition among suppliers.
• Focus on Cost Efficiency: Manufacturers prioritize optimizing production costs to remain competitive.

Demand Drivers

Demand for quetiapine fumarate is driven by:

• Prevalence of Mental Health Conditions: Increasing diagnoses of schizophrenia, bipolar disorder, and depression worldwide.
• Accessibility of Generics: The availability of affordable generic formulations globally.
• Off-Label Use: While controversial, off-label prescriptions for conditions like insomnia contribute to demand.

Quality and Supply Security Considerations

For pharmaceutical companies, securing a reliable supply of high-quality API is paramount. Factors influencing supplier selection include:

• Consistent Quality: Demonstrated through batch-to-batch uniformity and absence of impurities.
• Supply Chain Robustness: The ability to consistently meet demand without disruptions.
• Regulatory Audit Success: A history of successful inspections by regulatory bodies.
• Technical Support: The provision of comprehensive documentation and technical assistance.

Emerging Trends

• Sustainability in Manufacturing: Growing pressure on API manufacturers to adopt environmentally sustainable production processes.
• Advanced Impurity Profiling: Increased scrutiny on the identification and control of process-related impurities and degradants.
• Digitalization of Supply Chains: Adoption of digital tools for better traceability, inventory management, and supply chain visibility.

Key Suppliers of Quetiapine Fumarate API

The following table outlines some of the prominent manufacturers of quetiapine fumarate API. Note that the list is not exhaustive and market positions can shift.

Manufacturer Name	Country	Key Markets Served	Primary Certifications
Aurobindo Pharma	India	Global	USFDA, EMA, WHO-GMP, EDQM (CEP)
Dr. Reddy's Laboratories	India	Global	USFDA, EMA, WHO-GMP, EDQM (CEP)
Sun Pharmaceutical Industries	India	Global	USFDA, EMA, WHO-GMP, EDQM (CEP)
Zhejiang Huahai Pharmaceutical	China	Global	USFDA, EMA, WHO-GMP, EDQM (CEP)
Shandong Xinhua Pharmaceutical	China	Global	USFDA, EMA, WHO-GMP
Vamson Labs	France	Europe, Global	Varies; requires specific product registration and site compliance verification.
Laurus Labs	India	Global	USFDA, EMA, WHO-GMP
Divi's Laboratories	India	Global	USFDA, EMA, WHO-GMP

Note: Availability of specific certifications for each product requires direct verification with the manufacturer.

Formulation Manufacturers and Their API Sourcing

Leading generic drug manufacturers that formulate quetiapine fumarate into finished dosage forms rely on a diversified supplier base. Examples include:

• Teva Pharmaceutical Industries: A major global generic pharmaceutical company with extensive sourcing capabilities.
• Viatris Inc.: Formed by the merger of Mylan and Pfizer's Upjohn, Viatris has a broad portfolio and a significant global supply chain.
• Accord Healthcare: A rapidly growing generic manufacturer with a global presence.

These formulators typically conduct rigorous audits of their API suppliers to ensure quality, compliance, and supply continuity.

Challenges and Opportunities in the Supply Chain

The quetiapine fumarate supply chain faces inherent challenges and presents distinct opportunities.

Challenges

• Regulatory Scrutiny: Ever-increasing regulatory expectations regarding API purity, impurity profiling, and manufacturing process validation.
• Geopolitical Risks: Dependence on specific regions for API manufacturing can expose supply chains to geopolitical instability, trade disputes, and logistical disruptions.
• Environmental Regulations: Stricter environmental compliance requirements in manufacturing countries can lead to increased operational costs.
• Price Volatility: Fluctuations in raw material costs and competitive pressures can lead to price volatility for the API.

Opportunities

• Emerging Markets: Growth in demand for affordable mental health treatments in developing economies.
• Specialty APIs: Manufacturers with advanced capabilities in impurity control and complex synthesis can command premium pricing.
• Vertical Integration: Companies that control both API production and finished dosage form manufacturing can achieve greater supply chain control and cost efficiencies.
• Technological Advancements: Adoption of continuous manufacturing and other advanced processing technologies can improve efficiency and quality.

Key Takeaways

• The global supply of quetiapine fumarate API is heavily concentrated in India and China, with India being the dominant producer.
• Key API manufacturers are well-established pharmaceutical companies with extensive regulatory certifications, including USFDA and EMA.
• Patent expiries have intensified generic competition, leading to a focus on cost-effective production and supply chain efficiency.
• Formulation manufacturers prioritize API suppliers with consistent quality, robust supply chains, and strong regulatory compliance records.
• Challenges include increasing regulatory demands and geopolitical risks, while opportunities lie in emerging markets and technological advancements.

Frequently Asked Questions

1. What is the primary regulatory hurdle for API suppliers of quetiapine fumarate? The primary regulatory hurdle is obtaining and maintaining certifications from major health authorities, such as the USFDA and EMA, which often involves rigorous site inspections, comprehensive documentation (DMFs/ASMFs), and consistent batch quality.

2. How does the concentration of API manufacturing in India and China impact supply chain resilience? The concentration creates a single point of failure risk. Disruptions in these regions, whether due to natural disasters, geopolitical events, or regulatory crackdowns, can significantly impact global supply availability and pricing.

3. What are the key quality indicators pharmaceutical companies evaluate in quetiapine fumarate API suppliers? Key quality indicators include the absence of specified and unspecified impurities above regulatory thresholds, consistent polymorphic form, particle size distribution, water content, and heavy metal levels, all validated through Certificates of Analysis and supplier audits.

4. Are there significant differences in quality standards between API suppliers from India and China? While both regions have suppliers meeting international standards, quality can vary significantly at the individual company level. Manufacturers exporting to regulated markets (US, EU) typically adhere to stringent GMP, but diligence in supplier selection and auditing remains crucial for formulators.

5. What role do raw material availability and cost play in the quetiapine fumarate API market? The cost and availability of critical starting materials and intermediates directly influence the final API price. Fluctuations in these upstream components, often sourced from various global chemical suppliers, can impact the profitability and competitiveness of quetiapine fumarate API manufacturers.

Citations

[1] Aurobindo Pharma. (n.d.). API Business. Retrieved from https://www.aurobindo.com/ [2] Dr. Reddy's Laboratories. (n.d.). Active Pharmaceutical Ingredients. Retrieved from https://www.drreddys.com/ [3] Sun Pharmaceutical Industries. (n.d.). API Capabilities. Retrieved from https://www.sunpharma.com/ [4] Zhejiang Huahai Pharmaceutical Co., Ltd. (n.d.). API Products. Retrieved from http://www.huahai.cn/ [5] Shandong Xinhua Pharmaceutical Co., Ltd. (n.d.). API Division. Retrieved from http://www.xhpharm.com/